<DOC>
	<DOCNO>NCT00614315</DOCNO>
	<brief_summary>The objective clinical study evaluate performance Optimized FLAIR™ Delivery System .</brief_summary>
	<brief_title>FLAIR™ Delivery System Study</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<criteria>The subject either male nonpregnant female ≥ 18 year old . The subject properly inform study per IRB requirement , sign date IRBapproved ICF . The subject willing comply protocol requirement contact telephone . The subject synthetic AV access graft locate arm implant &gt; 30 day undergone least one successful dialysis session prior index procedure . Angiographic evidence indicates subject stenosis &gt; 50 % locate graftvein anastomosis subject 's synthetic AV access graft . The target lesion estimate ≤ 7 cm length angiography prior performance interventional procedure . The entire target lesion locate within 7 cm graftvein anastomosis , verify angiography , approximately 1 cm FLAIR™ Endovascular Stent Graft extend nondiseased vein approximately 1 cm 2 cm FLAIR™ Endovascular Stent Graft extend nondiseased AV graft . Graft diameter deployment site 5 mm 8 mm , verify angiography . Full expansion appropriately size angioplasty balloon , operator 's judgment , achieve primary angioplasty . The subject life expectancy &lt; 6 month . The presence previously place stent and/or stent graft locate treatment area . The treatment area define entire target lesion 1 cm land zone nondiseased AV graft nondiseased vein . The subject infect AV access graft infection . The location target lesion would require FLAIR™ Endovascular Stent Graft deploy fully across elbow joint . The location target lesion would require FLAIR™ Endovascular Stent Graft cross angle ( outflow vein synthetic AV access graft ) &gt; 90 degree . The subject uncorrected blood coagulation disorder . The subject know allergy sensitivity contrast medium adequately premedicated . Subject currently enrol schedule enrolled investigation conflict followup test confounds data trial . The subject know hypersensitivity nickeltitanium .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>